These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33512749)

  • 1. Selinexor, a First in Class, Nuclear Export Inhibitor for the Treatment of Advanced Malignant Peripheral Nerve Sheath Tumor.
    Al-Ezzi E; Gounder M; Watson G; Mazzocca A; D'Angelo SP; Bravetti J; Wang H; Abdul Razak A; Vincenzi B
    Oncologist; 2021 Apr; 26(4):e710-e714. PubMed ID: 33512749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant peripheral nerve sheath tumors.
    Gupta G; Maniker A
    Neurosurg Focus; 2007 Jun; 22(6):E12. PubMed ID: 17613203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary malignant peripheral nerve sheath tumors of bone: a clinicopathologic reappraisal of 8 cases.
    Gambarotti M; Righi A; Sbaraglia M; Cocchi S; Benini S; Magagnoli G; Frisoni T; Palmerini E; Picci P; Dei Tos AP
    Hum Pathol; 2022 Apr; 122():92-102. PubMed ID: 35176251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretome analysis of human schwann cells derived from malignant peripheral nerve sheath tumor.
    Ferdoushi A; Jamaluddin MFB; Li X; Pundavela J; Faulkner S; Hondermarck H
    Proteomics; 2022 Jan; 22(1-2):e2100063. PubMed ID: 34648240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death.
    Kashyap T; Argueta C; Aboukameel A; Unger TJ; Klebanov B; Mohammad RM; Muqbil I; Azmi AS; Drolen C; Senapedis W; Lee M; Kauffman M; Shacham S; Landesman Y
    Oncotarget; 2016 Nov; 7(48):78883-78895. PubMed ID: 27713151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma.
    Kuruvilla J; Savona M; Baz R; Mau-Sorensen PM; Gabrail N; Garzon R; Stone R; Wang M; Savoie L; Martin P; Flinn I; Jacoby M; Unger TJ; Saint-Martin JR; Rashal T; Friedlander S; Carlson R; Kauffman M; Shacham S; Gutierrez M
    Blood; 2017 Jun; 129(24):3175-3183. PubMed ID: 28468797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sporadic malignant peripheral nerve sheath tumour (MPNST) in a 3-year-old girl: A diagnostic challenge.
    Zawawi MSF; Wan Ismail WFN; Mustapar N; Mohamad N; Nasir A; Tuan Sharif SE
    Malays J Pathol; 2022 Apr; 44(1):115-120. PubMed ID: 35484894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase 1b trial of selinexor, a first-in-class selective inhibitor of nuclear export (SINE), in combination with doxorubicin in patients with advanced soft tissue sarcomas (STS).
    Lewin J; Malone E; Al-Ezzi E; Fasih S; Pedersen P; Accardi S; Gupta A; Abdul Razak A
    Eur J Cancer; 2021 Feb; 144():360-367. PubMed ID: 33418486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare case report of malignant peripheral nerve sheath tumor involving both the small bowel and large bowel.
    Khan N; Hashmi I; Atallah L; Shaaban H; Guron G; Fedida A
    Ann Afr Med; 2021; 20(3):228-231. PubMed ID: 34558453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.
    Varin J; Poulain L; Hivelin M; Nusbaum P; Hubas A; Laurendeau I; Lantieri L; Wolkenstein P; Vidaud M; Pasmant E; Chapuis N; Parfait B
    Oncotarget; 2016 Jun; 7(24):35753-35767. PubMed ID: 26840085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant Peripheral Nerve Sheath Tumor of the Cervix.
    Zhang T; Wang Z; Wang R; Wu X; Zhao M; Su F
    J Coll Physicians Surg Pak; 2022 Apr; 32(4):S24-S27. PubMed ID: 35633002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma.
    Gounder MM; Zer A; Tap WD; Salah S; Dickson MA; Gupta AA; Keohan ML; Loong HH; D'Angelo SP; Baker S; Condy M; Nyquist-Schultz K; Tanner L; Erinjeri JP; Jasmine FH; Friedlander S; Carlson R; Unger TJ; Saint-Martin JR; Rashal T; Ellis J; Kauffman M; Shacham S; Schwartz GK; Abdul Razak AR
    J Clin Oncol; 2016 Sep; 34(26):3166-74. PubMed ID: 27458288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method for quantification of exportin-1 (XPO1) occupancy by Selective Inhibitor of Nuclear Export (SINE) compounds.
    Crochiere ML; Baloglu E; Klebanov B; Donovan S; Del Alamo D; Lee M; Kauffman M; Shacham S; Landesman Y
    Oncotarget; 2016 Jan; 7(2):1863-77. PubMed ID: 26654943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.
    Thein KZ; Piha-Paul SA; Tsimberidou A; Karp DD; Janku F; Zarifa A; Shah J; Milton DR; Bean S; McQuinn L; Gong J; Colen R; Carter BW; Subbiah V; Ogbonna DC; Pant S; Meric-Bernstam F; Naing A
    Invest New Drugs; 2021 Oct; 39(5):1357-1365. PubMed ID: 33909232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic malignant peripheral nerve sheath tumor. A diagnostic surprise.
    Bai M; Govindaraj V; Chauhan AS; Srinivas BH; Sree Rekha J; Narenchandra V
    Monaldi Arch Chest Dis; 2021 May; 91(2):. PubMed ID: 34256542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Would a Massive Intra-abdominal Malignant Peripheral Nerve Sheath Tumor with Growth into the Inguinal Canal and Scrotum Preclude Surgical Option? A Case Report and Review of Literature.
    Agrawal A; Baskaran V; Jaiswal SS; Jayant HB
    Indian J Surg; 2013 Dec; 75(6):500-3. PubMed ID: 24465112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant peripheral nerve sheath tumor: pathology and genetics.
    Thway K; Fisher C
    Ann Diagn Pathol; 2014 Apr; 18(2):109-16. PubMed ID: 24418643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Targeted therapy for malignant peripheral nerve sheath tumor: translational research and clinical application].
    Liao ZC; Zhang C; Liu XY; Ren ZW; Xu J; Zhang CZ; Yang Y; Zhu Z; Yang JL
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):648-653. PubMed ID: 31550853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Options for Malignant Peripheral Nerve Sheath Tumors.
    Hassan A; Pestana RC; Parkes A
    Curr Treat Options Oncol; 2021 Feb; 22(4):33. PubMed ID: 33641042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues.
    Miller SJ; Rangwala F; Williams J; Ackerman P; Kong S; Jegga AG; Kaiser S; Aronow BJ; Frahm S; Kluwe L; Mautner V; Upadhyaya M; Muir D; Wallace M; Hagen J; Quelle DE; Watson MA; Perry A; Gutmann DH; Ratner N
    Cancer Res; 2006 Mar; 66(5):2584-91. PubMed ID: 16510576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.